DE SANTO, IRENE
 Distribuzione geografica
Continente #
EU - Europa 243
NA - Nord America 232
AS - Asia 99
SA - Sud America 17
AF - Africa 4
OC - Oceania 1
Totale 596
Nazione #
US - Stati Uniti d'America 225
RU - Federazione Russa 110
IT - Italia 77
SG - Singapore 54
HK - Hong Kong 26
BR - Brasile 17
DE - Germania 15
NL - Olanda 13
CN - Cina 11
FR - Francia 11
FI - Finlandia 6
CA - Canada 4
CI - Costa d'Avorio 4
UA - Ucraina 4
VN - Vietnam 4
IN - India 3
GB - Regno Unito 2
MX - Messico 2
AT - Austria 1
AU - Australia 1
BZ - Belize 1
IR - Iran 1
LT - Lituania 1
PL - Polonia 1
RS - Serbia 1
SE - Svezia 1
Totale 596
Città #
Chandler 67
Singapore 31
Moscow 27
Hong Kong 26
Napoli 24
Ashburn 16
Santa Clara 15
Amsterdam 12
Millbury 9
Casoria 6
Lawrence 6
Munich 6
Naples 6
Des Moines 4
Dong Ket 4
Milan 4
Turku 4
Battipaglia 3
Frankfurt am Main 3
Nanjing 3
New York 3
Seattle 3
Wilmington 3
Beijing 2
Caivano 2
Falkenstein 2
Helsinki 2
Jacksonville 2
London 2
Mexico City 2
Ottawa 2
Princeton 2
Pune 2
Roubaix 2
Salerno 2
São Paulo 2
Toronto 2
Angri 1
Araruama 1
Ardabil 1
Augusta 1
Belgrade 1
Belize City 1
Blumenau 1
Boardman 1
Boston 1
Brasília 1
Capitão Poço 1
Caserta 1
Catania 1
Conselheiro Lafaiete 1
Deiva Marina 1
Duncan 1
Duque de Caxias 1
Fairfield 1
Franca 1
Goiânia 1
Guangzhou 1
Hebei 1
Itapevi 1
Kronberg 1
Lauterbourg 1
Leawood 1
Los Angeles 1
Pavullo Nel Frignano 1
Philadelphia 1
Porto Alegre 1
Poços de Caldas 1
Redwood City 1
Sertãozinho 1
São Joaquim da Barra 1
Tianjin 1
Turin 1
Uberlândia 1
Vienna 1
Visconde do Rio Branco 1
Washington 1
Williamsburg 1
Yonkers 1
Totale 355
Nome #
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors. 100
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 99
Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction 78
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 73
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues 72
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 70
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 65
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study 59
Totale 616
Categoria #
all - tutte 2.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202168 1 0 4 15 8 1 13 4 10 1 7 4
2021/202256 0 2 2 0 1 1 1 4 1 4 22 18
2022/2023115 11 20 1 10 16 16 0 10 15 12 3 1
2023/202456 1 10 6 8 4 7 1 8 1 0 7 3
2024/2025285 10 10 4 10 7 25 19 19 14 31 119 17
Totale 616